There is a common misconception that “bio-based” means “compostable” or “weak.” In the high-stakes world of biopharmaceutical manufacturing, that couldn’t be further from the truth.
As we scale up single-use technologies (SUT) in 2026, understanding the origins and particularities of these materials is a compliance and sustainability imperative.
As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
Today, we’re proud to introduce Owen McMaster, our motivated and resourceful Project Manager / Engineer-in-Training (EIT).
Today, we’re proud to introduce the professional who bridges complex engineering with validated execution: Colin Young, our Project Manager and Validation Scientist.
I love the smell of a fresh Gantt chart in the morning. It’s the only time the project is actually on schedule.
Meet Petroslava “Petia” Ivanova, our Aseptic Filling & Sterile Manufacturing SME:
It is once again time for another instalment of our weekly feature: Meet-the-Team-Thursdays!
Today, we would like to introduce to you our esteemed colleague, John Teixeira:
Back in 2025, our company was a proud sponsor of the 2025 edition for Hope for Dementia’s annual gala. Let’s take a trip down memory lane!
We would like to introduce you to John Storrie, our Environmental Monitoring and GMP Training expert:
Let’s be honest, managing projects for bioprocessing facilities can feel like herding cats made of critical deadlines, regulatory demands, and a budget that’s always trying to escape.
But fear not, fellow project managers! We’ve got a secret weapon that turns chaos into controlled brilliance (most of the time): Risk-Based Project Management.
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
